TEK and systemic lupus erythematosus: Outstandingly, it was determined that this modulation is in turn mediated by Tie2 and type I IFN signalling pathways, suggesting a key contribution of type I IFN present in the serum of patients with SLE (46, 47) on the cardiovascular events observed in these patients.